Medical remains focus of Varian

Article

Medical equipment is one of four businesses remaining at a trimmed-downVarian Associates. The Palo Alto, CA, high-technology firm soldthe last of five non-core businesses last month, as it completedthe initial phase of a restructuring program. A U.K.

Medical equipment is one of four businesses remaining at a trimmed-downVarian Associates. The Palo Alto, CA, high-technology firm soldthe last of five non-core businesses last month, as it completedthe initial phase of a restructuring program. A U.K. broadcasttransmitter company was the last of the five to go.

Varian has raised over $60 million through the sale of nonstrategicbusinesses. These funds will be used in the second phase of thefirm's attempted financial turnaround: improving performance ofits core businesses of electron devices, analytical instruments,semiconductor equipment and medical equipment.

Varian produces linear accelerators for cancer therapy as wellas a variety of components for medical imaging equipment. Thecompany also holds basic patents in medical areas such as magneticresonance spectroscopy (SCAN 2/27/91), although Varian does notmarket MR scanners.

Varian/Eimac of Salt Lake City is a major supplier of replacementx-ray tubes and other imaging components for OEMs and independentservice organizations. Varian Canada Microwave Products is a supplierof power sources to OEMs for use in x-ray generators. The Canadianunit initiated a high-frequency retrofit program for CGR Senographemammography systems last year (SCAN 2/27/91).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.